173 related articles for article (PubMed ID: 37428746)
1. Differentiated service delivery models for antiretroviral treatment refills in Northern Nigeria: Experiences of people living with HIV and health care providers-A qualitative study.
Semo BW; Ezeokafor N; Adeyemi S; Kpamor Z; Mugo C
PLoS One; 2023; 18(7):e0287862. PubMed ID: 37428746
[TBL] [Abstract][Full Text] [Related]
2. Differentiated service delivery models among PLHIV in Akwa Ibom and Cross River States, Nigeria during the COVID-19 pandemic: descriptive analysis of programmatic data.
Sanwo O; Persaud NE; Nwaokoro P; Idemudia A; Akpan U; Toyo O; Imohi P; Badru T; Obiora-Okafo C; Uzochukwu CE; Aliu O; Olatunbosun K; Pandey SR; Khamofu H; Chiegil R; James E; Iyortim I; Oqua D; Bateganya M
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25820. PubMed ID: 34713591
[TBL] [Abstract][Full Text] [Related]
3. Understanding implementation barriers in the national scale-up of differentiated ART delivery in Uganda.
Zakumumpa H; Rujumba J; Kwiringira J; Katureebe C; Spicer N
BMC Health Serv Res; 2020 Mar; 20(1):222. PubMed ID: 32183796
[TBL] [Abstract][Full Text] [Related]
4. Differentiated service delivery: a qualitative study of people living with HIV and accessing care in a tertiary facility in Ghana.
Adjetey V; Obiri-Yeboah D; Dornoo B
BMC Health Serv Res; 2019 Feb; 19(1):95. PubMed ID: 30717715
[TBL] [Abstract][Full Text] [Related]
5. 'Only twice a year': a qualitative exploration of 6-month antiretroviral treatment refills in adherence clubs for people living with HIV in Khayelitsha, South Africa.
Keene CM; Zokufa N; Venables EC; Wilkinson L; Hoffman R; Cassidy T; Snyman L; Grimsrud A; Voget J; von der Heyden E; Zide-Ndzungu S; Bhardwaj V; Isaakidis P
BMJ Open; 2020 Jul; 10(7):e037545. PubMed ID: 32641338
[TBL] [Abstract][Full Text] [Related]
6. Benefits and challenges of community-based multi-month dispensing of antiretroviral treatment in Zimbabwe: A qualitative study from a cluster randomized trial.
Du Toit S; Marlow M; Mawoyo T; Chideya Y; Laurenzi C; Kasu T; Ngorima-Mabhena N; Grimwood A; Fatti G
Health Soc Care Community; 2022 Sep; 30(5):e2838-e2848. PubMed ID: 35064715
[TBL] [Abstract][Full Text] [Related]
7. Effects of the COVID-19 pandemic on HIV service delivery and viral suppression: Findings from the SHARP program in Northern Nigeria.
Mugo C; Adedokun O; Alo OD; Ezeokafor N; Adeyemi S; Kpamor Z; Madueke L; James E; Adebajo SB; Semo BW
PLoS One; 2024; 19(4):e0300335. PubMed ID: 38564514
[TBL] [Abstract][Full Text] [Related]
8. Implementing six multi-month dispensing of antiretroviral therapy in Ethiopia: perspectives of clients and healthcare workers.
Mantell JE; Zech JM; Masvawure TB; Assefa T; Molla M; Block L; Duguma D; Yirsaw Z; Rabkin M
BMC Health Serv Res; 2023 May; 23(1):563. PubMed ID: 37259098
[TBL] [Abstract][Full Text] [Related]
9. Client and provider preferences for HIV care: Implications for implementing differentiated service delivery in Thailand.
Lujintanon S; Amatavete S; Sungsing T; Seekaew P; Peelay J; Mingkwanrungruang P; Chinbunchorn T; Teeratakulpisarn S; Methajittiphan P; Leenasirima P; Norchaiwong A; Nilmanat A; Phanuphak P; Ramautarsing RA; Phanuphak N
J Int AIDS Soc; 2021 Apr; 24(4):e25693. PubMed ID: 33792192
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis treatment within differentiated service delivery models in global HIV/TB programming.
Tran CH; Moore BK; Pathmanathan I; Lungu P; Shah NS; Oboho I; Al-Samarrai T; Maloney SA; Date A; Boyd AT
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25809. PubMed ID: 34713974
[TBL] [Abstract][Full Text] [Related]
11. Differentiated service delivery for people using second-line antiretroviral therapy: clinical outcomes from a retrospective cohort study in KwaZulu-Natal, South Africa.
Lewis L; Sookrajh Y; Gate K; Khubone T; Maraj M; Mkhize S; Hermans LE; Ngobese H; Garrett N; Dorward J
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25802. PubMed ID: 34713545
[TBL] [Abstract][Full Text] [Related]
12. Patient experiences of ART adherence clubs in Khayelitsha and Gugulethu, Cape Town, South Africa: A qualitative study.
Venables E; Towriss C; Rini Z; Nxiba X; Cassidy T; Tutu S; Grimsrud A; Myer L; Wilkinson L
PLoS One; 2019; 14(6):e0218340. PubMed ID: 31220116
[TBL] [Abstract][Full Text] [Related]
13. Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia.
Jo Y; Jamieson L; Phiri B; Grimsrud A; Mwansa M; Shakwelele H; Haimbe P; Mukumbwa-Mwenechanya M; Mulenga PL; Nichols BE; Rosen S
PLoS One; 2023; 18(3):e0280748. PubMed ID: 36917568
[TBL] [Abstract][Full Text] [Related]
14. People living with HIV's perspectives of acceptability of fee for home delivery of ART: a qualitative study.
Ntinga X; Musiello F; Pita T; Mabaso N; Celum C; Szpiro A; van Rooyen H; Barnabas R; van Heerden A
BMC Health Serv Res; 2024 Jan; 24(1):88. PubMed ID: 38233824
[TBL] [Abstract][Full Text] [Related]
15. Optimizing differentiated treatment models for people living with HIV in urban Zimbabwe: Findings from a mixed methods study.
Rabkin M; Strauss M; Mantell JE; Mapingure M; Masvawure TB; Lamb MR; Zech JM; Musuka G; Chingombe I; Msukwa M; Boccanera R; Gwanzura C; George G; Apollo T
PLoS One; 2020; 15(1):e0228148. PubMed ID: 31990930
[TBL] [Abstract][Full Text] [Related]
16. Patient experiences and preferences for antiretroviral therapy service provision: implications for differentiated service delivery in Northwest Ethiopia.
Belay YA; Yitayal M; Atnafu A; Taye FA
AIDS Res Ther; 2022 Jun; 19(1):30. PubMed ID: 35761352
[TBL] [Abstract][Full Text] [Related]
17. HIV service delivery in the time of COVID-19: focus group discussions with key populations in India.
Pollard R; Gopinath U; Reddy YA; Kumar BR; Mugundu P; Vasudevan CK; Srikrishnan AK; Singh A; McFall AM; Mayer KH; Mehta SH; Solomon SS
J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25800. PubMed ID: 34713583
[TBL] [Abstract][Full Text] [Related]
18. Perceptions and factors associated with the uptake of the community client-led antiretroviral therapy delivery model (CCLAD) at a large urban clinic in Uganda: a mixed methods study.
Walusaga HAG; Atuyambe LM; Muddu M; Mpirirwe R; Nangendo J; Kalibbala D; Semitala FC; Katahoire AR
BMC Health Serv Res; 2023 Oct; 23(1):1165. PubMed ID: 37885014
[TBL] [Abstract][Full Text] [Related]
19. Expanding access to HIV services during the COVID-19 pandemic-Nigeria, 2020.
Boyd AT; Jahun I; Dirlikov E; Greby S; Odafe S; Abdulkadir A; Odeyemi O; Dalhatu I; Ogbanufe O; Abutu A; Asaolu O; Bamidele M; Onyenuobi C; Efuntoye T; Fagbamigbe JO; Ene U; Fagbemi A; Tingir N; Meribe C; Ayo A; Bassey O; Nnadozie O; Boyd MA; Onotu D; Gwamna J; Okoye M; Abrams W; Alagi M; Oladipo A; Williams-Sherlock M; Bachanas P; Chun H; Carpenter D; Miller DA; Ijeoma U; Nwaohiri A; Dakum P; Mensah CO; Aliyu A; Oyeledun B; Okonkwo P; Oko JO; Ikpeazu A; Aliyu G; Ellerbrock T; Swaminathan M
AIDS Res Ther; 2021 Sep; 18(1):62. PubMed ID: 34538268
[TBL] [Abstract][Full Text] [Related]
20. 'Side effects' are 'central effects' that challenge retention in HIV treatment programmes in six sub-Saharan African countries: a multicountry qualitative study.
Renju J; Moshabela M; McLean E; Ddaaki W; Skovdal M; Odongo F; Bukenya D; Wamoyi J; Bonnington O; Seeley J; Zaba B; Wringe A
Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
